p300/CBP degradation is required to disable the active AR enhanceosome in prostate cancer

Jie Luo(University of South China), Arul M. Chinnaiyan(University of Michigan)
bioRxiv (Cold Spring Harbor Laboratory)
March 30, 2024
Cited by 10


Related Papers